SCHEMBL23383232

SCHEMBL23383232

CC1(C)c2ccccc2C2(c3ccccc3-c3c(N(c4ccc(-c5ccccc5)cc4)c4cccc5c4sc4ccccc45)cccc32)c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.34
PARP14 Q460N5 1/20 0.31
PTPN1 P18031 1/20 0.30
F9 P00740 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16810670 0.95 ALOX5 (0.36) ALOX5PARP14
SCHEMBL21922861 0.95 ALOX5 (0.36) ALOX5PARP14
SCHEMBL21559163 0.94 ALOX5 (0.39) ALOX5PARP14PTPN1F9
SCHEMBL21037291 0.94 PARP14 (0.32) ALOX5PARP14
SCHEMBL24255732 0.94 ALOX5 (0.37) ALOX5PARP14PTPN1F9
SCHEMBL23383070 0.94 PARP14 (0.33) ALOX5PARP14
SCHEMBL17816782 0.94 ALOX5 (0.37) ALOX5PARP14PTPN1F9
SCHEMBL25145854 0.93 ALOX5 (0.36) ALOX5PARP14PTPN1F9
SCHEMBL23383238 0.91 ALOX5 (0.35) ALOX5PARP14F9
SCHEMBL23382966 0.91 ALOX5 (0.36) ALOX5F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147336-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME DOOSAN SOLUS CO., LTD. (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147336-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME OR10J3, ORAI2, OR51E2 ALOX5 398/4885PARP14 1581/4885PTPN1 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.